<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id>
      <journal-title>BMC Medical Genetics</journal-title>
      <issn pub-type="epub">1471-2350</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">17257434</article-id>
      <article-id pub-id-type="pmc">1790885</article-id>
      <article-id pub-id-type="publisher-id">1471-2350-8-2</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2350-8-2</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Transient trimethylaminuria related to menstruation</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" contrib-type="author">
          <name>
            <surname>Shimizu</surname>
            <given-names>Makiko</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>shimizu@ac.shoyaku.ac.jp</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Cashman</surname>
            <given-names>John R</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>jcashman@hbri.org</email>
        </contrib>
        <contrib id="A3" corresp="yes" contrib-type="author">
          <name>
            <surname>Yamazaki</surname>
            <given-names>Hiroshi</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>hyamazak@ac.shoyaku.ac.jp</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Machida, Tokyo 194-8543, Japan</aff>
      <aff id="I2"><label>2</label>Human BioMolecular Research Institute, San Diego, CA 92121, USA</aff>
      <pub-date pub-type="collection">
        <year>2007</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>27</day>
        <month>1</month>
        <year>2007</year>
      </pub-date>
      <volume>8</volume>
      <fpage>2</fpage>
      <lpage>2</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2350/8/2"/>
      <history>
        <date date-type="received">
          <day>28</day>
          <month>10</month>
          <year>2006</year>
        </date>
        <date date-type="accepted">
          <day>27</day>
          <month>1</month>
          <year>2007</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2007 Shimizu et al; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2007</copyright-year>
        <copyright-holder>Shimizu et al; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
          <!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               Shimizu
               Makiko
               
               shimizu@ac.shoyaku.ac.jp
            </dc:author><dc:title>
            Transient trimethylaminuria related to menstruation
         </dc:title><dc:date>2007</dc:date><dcterms:bibliographicCitation>BMC Medical Genetics 8(1): 2-. (2007)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2350(2007)8:1&#x0003c;2&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2350</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>-->
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Trimethylaminuria, or fish odor syndrome, includes a transient or mild malodor caused by an excessive amount of malodorous trimethylamine as a result of body secretions. Herein, we describe data to support the proposal that menses can be an additional factor causing transient trimethylaminuria in self-reported subjects suffering from malodor and even in healthy women harboring functionally active flavin-containing monooxygenase 3 (FMO3).</p>
        </sec>
        <sec sec-type="methods">
          <title>Methods</title>
          <p>FMO3 metabolic capacity (conversion of trimethylamine to trimethylamine <italic>N</italic>-oxide) was defined as the urinary ratio of trimethylamine <italic>N</italic>-oxide to total trimethylamine.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>Self-reported Case (A) that was homozygous for inactive Arg500stop FMO3, showed decreased metabolic capacity of FMO3 (i.e., ~10% the unaffected metabolic capacity) during 120 days of observation. For Case (B) that was homozygous for common [Glu158Lys; Glu308Gly] <italic>FMO3 </italic>polymorphisms, metabolic capacity of FMO3 was almost ~90%, except for a few days surrounding menstruation showing &lt; 40% metabolic capacity. In comparison, three healthy control subjects that harbored heterozygous polymorphisms for [Glu158Lys; Glu308Gly] <italic>FMO3 </italic>or homozygous for wild <italic>FMO3 </italic>showed normal (&gt; 90%) metabolic capacity, however, on days around menstruation the FMO3 metabolic capacity was decreased to ~60&#x2013;70%.</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>Together, these results indicate that abnormal FMO3 capacity is caused by menstruation particularly in the presence, in homozygous form, of mild genetic variants such as [Glu158Lys; Glu308Gly] that cause a reduced FMO3 function.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Trimethylaminuria, or fish odor syndrome, includes a transient or mild malodor caused by an excessive amount of malodorous trimethylamine as a result of body secretions [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>]. The causal factor of excessive free trimethylamine is reduced enzyme capacity, or maybe substrate overload. The decreased enzyme capacity to form non-odorous trimethylamine <italic>N</italic>-oxide could be a result by an inherited deficiency (primary genetic trimethylaminuria) and/or by hormonal modulation or liver damage (transient trimethylaminuria) [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>]. For trimethylaminuria, at least 40 genetic polymorphisms of the <italic>flavin-containing monooxygenase 3 </italic>(<italic>FMO3</italic>) gene have been reported [<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. For transient trimethylaminuria, a change of metabolic capacity in one individual around the time of menstruation has been reported [<xref ref-type="bibr" rid="B6">6</xref>]. Herein, we describe data to support the proposal that menses can be an additional factor causing transient trimethylaminuria in self-reported subjects suffering from malodor and even in healthy women harboring functionally active FMO3.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <p>Japanese female volunteers included two subjects suffering self-reported malodor that responded to an Internet article and three healthy laboratory members as controls, ranging from 21 to 37 years of age [<xref ref-type="bibr" rid="B5">5</xref>,<xref ref-type="bibr" rid="B7">7</xref>]. Written consent was obtained from the individuals for publication of study. FMO3 metabolic capacity (conversion of trimethylamine to trimethylamine <italic>N</italic>-oxide) was defined as the urinary ratio of trimethylamine <italic>N-</italic>oxide to total trimethylamine (% of trimethylamine <italic>N</italic>-oxide/[trimethylamine + trimethylamine <italic>N</italic>-oxide]) determined by GC [<xref ref-type="bibr" rid="B7">7</xref>]. The <italic>FMO3 </italic>DNA sequence of genomic DNA prepared from peripheral lymphocytes or buccal cells from the study participants was also analyzed [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. The study participants collected their urine samples using a procedure described previously [<xref ref-type="bibr" rid="B7">7</xref>]. The ethics committee of Showa Pharmaceutical University approved this study.</p>
    </sec>
    <sec>
      <title>Results and discussion</title>
      <p>As shown in Figure <xref ref-type="fig" rid="F1">1</xref>, Case (A) that was homozygous for inactive Arg500stop <italic>FMO3 </italic>[<xref ref-type="bibr" rid="B5">5</xref>], showed decreased metabolic capacity of FMO3 (i.e., 13 &#xB1; 10 % (mean &#xB1; SD, n = 20) of the unaffected metabolic capacity) during 120 days of observation. For Case (B) that was homozygous for common [Glu158Lys; Glu308Gly] <italic>FMO3 </italic>polymorphisms [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>], metabolic capacity of FMO3 was almost ~90%, except for a few days surrounding menstruation. In comparison, healthy control Case (C) that harbored heterozygous polymorphisms for [Glu158Lys; Glu308Gly] <italic>FMO3 </italic>showed &gt; 90% metabolic capacity and this was greater than the reported unaffected ratio [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B7">7</xref>]. However, for Case (C), on days around menstruation the FMO3 metabolic capacity was decreased to ~60&#x2013;70%. Control Cases (D) and (E) that were homozygous for wild <italic>FMO3 </italic>also showed normal FMO3 metabolic capacity (i.e., ~&gt; 90%), except for days around menstruation. Together, these results indicate that abnormal FMO3 capacity is caused by menstruation particularly in the presence, in homozygous form, of mild genetic variants such as [Glu158Lys; Glu308Gly] that cause a reduced FMO3 function. This would further suggest that sex hormones play a role in the variable regulation of FMO3. Induced FMO3 activity during pregnancy [<xref ref-type="bibr" rid="B8">8</xref>] has been reported, in accordance with the present results.</p>
      <fig position="float" id="F1">
        <label>Figure 1</label>
        <caption>
          <p>Decreased metabolic capacity of FMO3 (&#x25B3;), as indicated as percent free trimethylamine (TMA, &#x25CF;) to total trimethylamine (&#x25CB;) excreted in the urine, in relation to menstruation. Filled boxes indicate the period of menstruation. Total urinary trimethylamine and free trimethylamine concentrations were calculated as mmol trimethylamine (TMA)/mol creatinine. Cases (A) and (B) were self-reported subjects suffering from malodour genotyped for homozygotic inactive Arg500stop <italic>FMO3 </italic>and homozygotic common [Glu158Lys; Glu308Gly] <italic>FMO3</italic>, respectively. Cases (C) and (D and E) were control subjects genotyped as heterozygotic for [Glu158Lys; Glu308Gly] <italic>FMO3 </italic>and homozygotic for wild <italic>FMO3</italic>, respectively.</p>
        </caption>
        <graphic xlink:href="1471-2350-8-2-1"/>
      </fig>
    </sec>
    <sec>
      <title>Conclusion</title>
      <p>Menses can be a factor causing transient trimethylaminuria even in healthy women harboring active enzymes. The present information could be useful in relieving the symptoms for transient and/or mild trimethylaminuria for affected females during menstruation.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The author(s) declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>MS undertook genotyping and some analyses. JRC was involved in the supervision of the project and revised the paper. HY undertook planning and most analyses and drafted the paper. All authors read and approved the final manuscript.</p>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2350/8/2/prepub"/>
      </p>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgements</title>
        <p>This study was supported in part by the Ministry of Education, Science, Sports and Culture of Japan and Japan Research Foundation for Clinical Pharmacology. JRC was supported financially by a grant from NIH (Grant Number DK 59618).</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zschocke</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kohlmueller</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Quak</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Meissner</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Hoffmann</surname>
              <given-names>GF</given-names>
            </name>
            <name>
              <surname>Mayatepek</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Mild trimethylaminuria caused by common variants in FMO3 gene</article-title>
          <source>Lancet</source>
          <year>1999</year>
          <volume>354</volume>
          <fpage>834</fpage>
          <lpage>835</lpage>
          <pub-id pub-id-type="pmid">10485731</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mitchell</surname>
              <given-names>SC</given-names>
            </name>
          </person-group>
          <article-title>Trimethylaminuria: susceptibility of heterozygotes</article-title>
          <source>Lancet</source>
          <year>1999</year>
          <volume>354</volume>
          <fpage>2164</fpage>
          <lpage>2165</lpage>
          <pub-id pub-id-type="pmid">10609842</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(05)77067-7</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamazaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fujieda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Cashman</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Kamataki</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Mild trimethylaminuria observed in a Japanese cohort with liver damage</article-title>
          <source>Am J Med</source>
          <year>2005</year>
          <volume>118</volume>
          <fpage>803</fpage>
          <lpage>805</lpage>
          <pub-id pub-id-type="pmid">15989923</pub-id>
          <pub-id pub-id-type="doi">10.1016/j.amjmed.2004.08.015</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hernandez</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Addou</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Orengo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Shephard</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>IR</given-names>
            </name>
          </person-group>
          <article-title>Trimethylaminuria and a human FMO3 mutation database</article-title>
          <source>Hum Mutat</source>
          <year>2003</year>
          <volume>22</volume>
          <fpage>209</fpage>
          <lpage>213</lpage>
          <pub-id pub-id-type="pmid">12938085</pub-id>
          <pub-id pub-id-type="doi">10.1002/humu.10252</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamazaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fujita</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Gunji</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Kamataki</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Cashman</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Shimizu</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Stop codon mutations in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population</article-title>
          <source>Mol Genet Metab</source>
          <year>2007</year>
          <volume>90</volume>
          <fpage>58</fpage>
          <lpage>63</lpage>
          <pub-id pub-id-type="pmid">16996766</pub-id>
          <pub-id pub-id-type="doi">10.1016/j.ymgme.2006.08.008</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>AQ</given-names>
            </name>
            <name>
              <surname>Mitchell</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Smith</surname>
              <given-names>RL</given-names>
            </name>
          </person-group>
          <article-title>Exacerbation of symptoms of fish-odour syndrome during menstruation</article-title>
          <source>Lancet</source>
          <year>1996</year>
          <volume>348</volume>
          <fpage>1740</fpage>
          <lpage>1741</lpage>
          <pub-id pub-id-type="pmid">8973460</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0140-6736(05)65872-2</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yamazaki</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Fujieda</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Togashi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Saito</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Preti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Cashman</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Kamataki</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Effects of the dietary supplements, activated charcoal and copper chlorophyllin, on urinary excretion of trimethylamine in Japanese trimethylaminuria patients</article-title>
          <source>Life Sci</source>
          <year>2004</year>
          <volume>74</volume>
          <fpage>2739</fpage>
          <lpage>2747</lpage>
          <pub-id pub-id-type="pmid">15043988</pub-id>
          <pub-id pub-id-type="doi">10.1016/j.lfs.2003.10.022</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hukkanen</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dempsey</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Jacob</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Benowitz</surname>
              <given-names>NL</given-names>
            </name>
          </person-group>
          <article-title>Effect of pregnancy on a measure of FMO3 activity</article-title>
          <source>British Journal of Clinical Pharmacology</source>
          <year>2005</year>
          <volume>60</volume>
          <fpage>224</fpage>
          <lpage>226</lpage>
          <pub-id pub-id-type="pmid">16042678</pub-id>
          <pub-id pub-id-type="doi">10.1111/j.1365-2125.2005.02406.x</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
